Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Single blood test accurately detects tick-borne diseases
The TBD Serochip can also identify whether an individual is infected with more than one tick-borne pathogen.

TBD Serochip can identify eight different pathogens

Scientists in America have developed a revolutionary new blood test for tick-borne diseases.

The Tick-Borne Disease Serochip (TBD Serochip) promises to make diagnosis easier, providing a single test for eight different tick-borne pathogens, including Lyme disease.

The research was led by the Centre for Infection and Immunity (CII) at Columbia University’s Mailman School of Public Health and reported in the journal Nature Scientific Reports.

Diagnosis of Lyme disease currently requires two separate tests and relies on subjective criteria for the interpretation of results. This complex approach accurately identifies less than 40 per cent of patients
and provides false positives 28 per cent of the time.

Scientists report that the TBD Serochip can simultaneously test for the presence of antibodies in blood to more than 170,000 individual fragments of protein. In addition to Lyme disease, it can also identify Anaplasma, Babesia, Borrelia burgdorferi, Borrelia miyamotoi, Ehrlichia, Rickettsia, Heartland virus, and Powassan virus.

The TBD Serochip can also identify whether an individual is infected with more than one tick-borne pathogen, researchers say. Individual ticks are often infected with more than one agent; Ixodes scapularis ticks alone can transmit at least five human pathogens.

Evidence of exposure to other tick-borne pathogens in patients with Lyme disease has been well documented. In this latest paper, the scientists note finding antibodies to another agent in 26 per cent of blood specimens from patients with TBD.

“Diagnosing tick-borne illness is a difficult journey for patients, delaying effecting treatment,” says senior author W. Ian Lipkin. “The TBD Serochip promises to make diagnosis far easier, offering a single, accurate test for eight different TBDs. Early detection of infection enables rapid and appropriate treatment.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.